Q4 2015 Holdings
Filed 2016-02-12 | 19 holdings | $112.8K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Wave Life Sciences Ltd.(WVE) | SHS | Y95308105 | $22.5K | 1,410,689 | 20.0% |
| Global Blood Therapeutics, Inc. | COM | 37890U108 | $14.9K | 460,000 | 13.2% |
| Alder BioPharmaceuticals, Inc.(ALDR1EUR) | COM | 014339105 | $7.6K | 229,895 | 6.7% |
| Epizyme, Inc.(EPZMEUR) | COM | 29428V104 | $7.4K | 461,651 | 6.6% |
| Zafgen, Inc. | COM | 98885E103 | $6.9K | 1,099,700 | 6.1% |
| Aimmune Therapeutics, Inc.(AIMT) | COM | 00900T107 | $6.6K | 355,020 | 5.8% |
| Regulus Therapeutics Inc. | COM | 75915K101 | $6.3K | 718,997 | 5.6% |
| Aerie Pharmaceuticals, Inc.(AERIEUR) | COM | 00771V108 | $5.7K | 232,757 | 5.0% |
| Orexigen Therapeutics, Inc. | COM | 686164104 | $5.2K | 3,000,000 | 4.6% |
| Acceleron Pharma Inc.(XLRN)Put | COM | 00434H108 | $4.9K | 100,000 | 4.3% |
| Intersect ENT, Inc. | COM | 46071F103 | $4.5K | 200,000 | 4.0% |
| NeuroDerm Ltd. | ORD SHS | M74231107 | $4.5K | 261,945 | 4.0% |
| Lipocine Inc. | COM | 53630X104 | $4.3K | 330,000 | 3.8% |
| Akari Therapeutics, PLC | SPONSORED ADR | 00972G108 | $3.8K | 263,921 | 3.4% |
| Acceleron Pharma Inc.(XLRN) | COM | 00434H108 | $2.4K | 50,047 | 2.2% |
| Dyax CorpCall | COM | 26746E103 | $2.1K | 55,900 | 1.9% |
| Regenxbio Inc.(RGNX) | COM | 75901B107 | $1.7K | 100,000 | 1.5% |
| Dimension Therapeutics, Inc. | COM | 25433V105 | $1.1K | 98,297 | 1.0% |
| ImmunoGen, Inc.(IMGNEUR) | COM | 45253H101 | $581 | 42,815 | 0.5% |